Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 21, 2012; 18(39): 5570-5575
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5570
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5570
Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients
Etsuro Orito, Kei Fujiwara, Hiroshi Kanie, Tesshin Ban, Tomonori Yamada, Katsumi Hayashi, Department of Gastroenterology, Nagoya Daini Red Cross Hospital, Nagoya 466-8650, Japan
Author contributions: Orito E, Fujiwara K, Kanie H, Ban T, Yamada T and Hayashi K designed the study, enrolled the patients, analyzed the data, and drafted the manuscript; and Ban T contributed to the statistical analysis.
Supported by A grant from the Japanese Ministry of Health and Welfare
Correspondence to: Etsuro Orito, MD, PhD, Department of Gastroenterology, Nagoya Daini Red Cross Hospital, Myoken-cho 2-9, Showa, Nagoya 466-8650, Japan. orito@nagoya2.jrc.or.jp
Telephone: +81-52-8321121 Fax: +81-52-8325369
Received: February 10, 2012
Revised: March 28, 2012
Accepted: April 9, 2012
Published online: October 21, 2012
Revised: March 28, 2012
Accepted: April 9, 2012
Published online: October 21, 2012
Core Tip